ADAGE CAPITAL PARTNERS GP, L.L.C. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 172 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$10,906,000
-54.0%
950,000
-32.1%
0.03%
-43.4%
Q3 2018$23,730,000
-48.6%
1,400,000
-56.9%
0.05%
-50.0%
Q2 2018$46,150,000
+5.6%
3,250,000
+41.3%
0.11%
+3.9%
Q1 2018$43,700,000
+11.0%
2,300,000
-4.2%
0.10%
+14.6%
Q4 2017$39,360,000
-18.0%
2,400,000
-25.0%
0.09%
-23.9%
Q3 2017$48,000,000
+36.4%
3,200,000
-20.0%
0.12%
+36.0%
Q2 2017$35,200,000
+125.6%
4,000,000
+33.3%
0.09%
+120.5%
Q1 2017$15,600,000
+104.6%
3,000,000
+20.0%
0.04%
+85.7%
Q4 2016$7,625,000
-34.1%
2,500,0000.0%0.02%
-34.4%
Q3 2016$11,575,000
-20.0%
2,500,0000.0%0.03%
-17.9%
Q2 2016$14,475,000
+29.3%
2,500,000
+35.1%
0.04%
+30.0%
Q1 2016$11,193,000
+36.2%
1,850,000
+105.6%
0.03%
+36.4%
Q4 2015$8,217,000
+61.9%
900,0000.0%0.02%
+57.1%
Q3 2015$5,076,000
-66.1%
900,000
-33.3%
0.01%
-62.2%
Q2 2015$14,972,000
-26.6%
1,350,000
+3.8%
0.04%
-26.0%
Q1 2015$20,384,000
-41.7%
1,300,000
-43.5%
0.05%
-41.9%
Q4 2014$34,983,000
+27.2%
2,300,000
-9.8%
0.09%
+26.5%
Q3 2014$27,502,000
-29.4%
2,550,0000.0%0.07%
-32.7%
Q2 2014$38,939,000
-23.1%
2,550,000
-8.9%
0.10%
-26.8%
Q1 2014$50,624,000
+2.7%
2,800,000
-21.1%
0.14%
+5.3%
Q4 2013$49,310,000
+26.1%
3,550,000
-4.8%
0.13%
+17.0%
Q3 2013$39,105,000
+257.6%
3,727,800
+166.3%
0.11%
+229.4%
Q2 2013$10,934,000
+107.9%
1,400,000
+154.5%
0.03%
+100.0%
Q1 2013$5,258,000550,0000.02%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders